This is a competitive renewal application for continued support of a postdoctoral research career development program for obstetrician-gynecologists. It is sponsored jointly by the NIH/NICHD, four professional organizations, and three pharmaceutical corporations. The objective of this program is to educate obstetrician-gynecologists in basic science research and to help prepare them for careers in academic medicine. This goal is to help ensure that academic obstetrics and gynecology fulfills its mission to increase research and understanding in the reproductive sciences. Ph.D. and M.D. scientists with broad-based research experience will serve as the core faculty. This Program is administered by an ad hoc Executive Committee consisting of academic faculty and appointees from the following organizations: the American College of Obstetricians and Gynecologists, the American Fertility Society, the American Gynecological and Obstetrical Society, the Association of Professors of Gynecology and Obstetrics, the Society for Gynecologic Investigation, Berlex Foundation, Ethicon, Inc., and GynoPharma, Inc., in conjunction with the National Institute of Child Health and Human Development. A unique feature of this Program is that outstanding individuals, upon completion of their residency, and usually two years of clinical subspecialty fellowship, spend two years in basic research training in cell and/or molecular biology (Phase I), and an additional three-year period establishing their research program in a Department of Obstetrics and Gynecology (Phase II). The laboratory, identified as providing an outstanding environment for basic research training,is selected by the candidate with advice and approval of the Executive Committee. During Phase I of the Program, the awardees devote themselves to full time research. Following this two years of basic science research, the awardee spends three years as a junior faculty member in a Department of Obstetrics and Gynecology with at least 75% time free for research under an identified preceptor. This Phase II period is funded by the sponsoring department. Upon the completion of this program, the candidate is expected to enter a productive investigative career, and to continue to devote a majority of his/her time to research. In such a position one should be competitive for starter research grants. This Program may serve as a model to educate increased numbers of reproductive scientists for academic medicine and Departments of Obstetrics and Gynecology.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12HD000849-07
Application #
2194359
Study Section
Population Research Committee (HDPR)
Project Start
1988-09-01
Project End
1998-06-30
Budget Start
1994-07-01
Budget End
1995-06-30
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Mhatre, Mohak; Adeli, Sharareh; Norwitz, Errol et al. (2018) The Effect of Maternal Obesity on Placental Cell-Free DNA Release in a Mouse Model. Reprod Sci :1933719118811647
Brayboy, Lynae M; McCoy, Katryna; Thamotharan, Sneha et al. (2018) The use of technology in the sexual health education especially among minority adolescent girls in the United States. Curr Opin Obstet Gynecol 30:305-309
Yu, Bo; Vega, Mario; Zaghi, Sahar et al. (2018) Comparison of perinatal outcomes following frozen embryo transfer cycles using autologous versus donor oocytes in women 40 to 43 years old: analysis of SART CORS data. J Assist Reprod Genet 35:2025-2029
Roberts, Victoria H J; Lo, Jamie O; Lewandowski, Katherine S et al. (2018) Adverse Placental Perfusion and Pregnancy Outcomes in a New Nonhuman Primate Model of Gestational Protein Restriction. Reprod Sci 25:110-119
Lo, Jamie O; Roberts, Victoria H J; Schabel, Matthias C et al. (2018) Novel Detection of Placental Insufficiency by Magnetic Resonance Imaging in the Nonhuman Primate. Reprod Sci 25:64-73
Quinn, Jeanne M; Greenwade, Molly M; Palisoul, Marguerite L et al. (2018) Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer. Mol Cancer Ther :
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Grither, Whitney R; Divine, Laura M; Meller, Eric H et al. (2018) TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis. Oncogene 37:1714-1729
Edlow, Andrea G; Glass, Ruthy M; Smith, Caroline J et al. (2018) Placental Macrophages: A Window Into Fetal Microglial Function in Maternal Obesity. Int J Dev Neurosci :
Kallen, Amanda; Polotsky, Alex J; Johnson, Joshua (2018) Untapped Reserves: Controlling Primordial Follicle Growth Activation. Trends Mol Med 24:319-331

Showing the most recent 10 out of 294 publications